Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection: Eosinophils mediate airway hyperresponsiveness, M2 muscarinic receptor dysfunction, and antiviral effects

Journal of Experimental Medicine

Volumn 190, Issue 10, 1999, Pages 1465-1477

  Adamko, Darryl J ^b   Yost, Bethany L ^a   Gleich, Gerald J ^c   Fryer, Allison D ^a   Jacoby, David B ^a,b  

^a School of Hygiene and Public Health   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Antigen challenge; Eosinophils; Muscarinic receptors; Parainfluenza virus; Viral immunity

Indexed keywords

ACETYLCHOLINE; INTERLEUKIN 5; MAJOR BASIC PROTEIN; MUSCARINIC RECEPTOR; OVALBUMIN;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; EOSINOPHILIA; GUINEA PIG; INFLAMMATION; NONHUMAN; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; SENSITIZATION; VIRUS IMMUNITY;

ANIMALS; BLOOD PRESSURE; BRONCHIAL HYPERREACTIVITY; EOSINOPHILS; FEMALE; GUINEA PIGS; HEART RATE; IMMUNIZATION; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-5; NITRIC OXIDE; OVALBUMIN; PARAMYXOVIRIDAE INFECTIONS; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; VAGUS NERVE;

EID: 0033571468     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.10.1465     Document Type: Article

References (52)

1. Johnston, S., P. Pattermore, G. Sanderson, S. Smith, F. Lampe, L. Josephs, P. Symington, S. O'Toole, S. Myint, D. Tyrell, and S. Holgate. 1995. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 310:1225-1229.
2. Empey, D.W., L.A. Laitinen, L. Jacobs, W.M. Gold, and J.A. Nadel. 1976. Mechanisms of bronchial hyperreactivity in normal subjects following upper respiratory tract infection. Am. Rev. Respir. Dis. 113:523-527.
3. Nadel, J.A., and P.J. Barnes. 1984. Autonomie regulation of the airways. Annu. Rev. Med. 35:451-467.
4. 3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm. Pharmacol. 3:47-51.
5. Fryer, A.D., and J. Maclagan. 1984. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br. J. Pharmacol. 83:973-978.
6. Fryer, A.D., R.W. Costello, B.L. Yost, R.R. Lobb, T.F. Tedder, A.S. Steeber, and B.S. Bochner. 1997. Antibody to VLA-4, but not to L-selectin, protects neuronal M2 muscarinic receptors in antigen-challenged guinea pig airways. J. Clin. Invest. 99:2036-2044.
7. Elbon, C.L., D.B. Jacoby, and A.D. Fryer. 1995. Pretreatment with an antibody to IL-5 preserves the function of pulmonary M2 muscarinic receptors in antigen challenged guinea-pigs. Am. J. Respir. Cell Mol. Biol. 12:320-328.
8. Jacoby, D.B., G.J. Gleich, and A.D. Fryer. 1993. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J. Clin. Invest. 91:1314-1318.
9. Fryer, A.D., and D.B. Jacoby. 1992. Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-1-glutamate. J. Clin. Invest. 90: 2292-2298.
10. Evans, C.M., D.B. Jacoby, G.J. Gleich, A.D. Fryer, and R.W. Costello. 1997. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 receptor function in antigen-challenged guinea pigs. J. Clin. Invest. 100:2254-2262.
11. Fryer, A.D., K.A. Yarkony, and D.B. Jacoby. 1994. The effect of leukocyte depletion on pulmonary M2 muscarinic receptor function in parainfluenza virus-infected guinea-pigs. Br. J. Pharmacol. 112:588-594.
12. + cells can switch to interleukin 5 production and induce airway eosinophilia. J. Exp. Med. 181:1229-1233.
13. Lewis, D.M., D.A. Loegering, and G.J. Gleich. 1976. Antiserum to the major basic protein of guinea pig eosinophil granules. Immunochemistry. 13:743-746.
14. Fryer, A.D., and M. Wills-Karp. 1991. Dysfunction of M2-muscarinic receptors in pulmonary parasympathetic nerves after antigen challenge. J. Appl. Physiol. 71:2255-2261.
15. Costello, R.W., C.M. Evans, B.L. Yost, K.E. Belmonte, G.J. Gleich, D.B. Jacoby, and A.D. Fryer. 1999. Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils. Am. J. Physiol. 20:L709-L714.
16. Walsh, J.J., L.F. Dietlein, F.N. Low, G.E. Burch, and W.J. Mogabgab. 1960. Bronchotracheal response in human influenza. Arch. Int. Med. 108:376-388.
17. Ramshaw, I., A. Ramsay, G. Karupiah, M. Rolph, S. Mahalingam, and J. Ruby. 1997. Cytokines and immunity to viral infection. Immunol. Rev. 159:119-135.
18. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 180:1273-1282.
19. Garofalo, R., J.L. Kimpen, R.C. Welliver, and P.L. Ogra. 1992. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120:28-32.
20. Teran, L.M., M.C. Seminario, J.K. Shute, A. Papi, S.J. Compton, J.L. Low, G.J. Gleich, and S.L. Johnston. 1999. RANTES, macrophage-inhibitory protein 1α, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children. J. Infect. Dis. 179:677-681.
21. Bardin, P.G., D.J. Fraenkel, G. Sanderson, F. Lampe, and S.T. Holgate. 1995. Lower airways inflammatory response during rhinovirus colds. Int. Arch. Allergy Immunol. 107: 127-129.
22. Frigas, E., D.A. Loegering, G.O. Solley, G.M. Farrow, and G.J. Gleich. 1981. Elevated levels of the eosinophil granule MBP in the sputum of patients with bronchial asthma. Mayo Clin. Proc. 56:345-353.
23. Rakes, G.P., E. Arruda, J.M. Ingram, G.E. Hoover, J.C. Zambrano, F.G. Hayden, T.A.E. Platts-Mills, and P.W. Heymann. 1999. Rhinovirus and respiratory syncytial virus in wheezing children requires emergency care: IgE and eosinophil analyses. Am. J. Respir. Crit. Care Med. 159:785-790.
24. Li, L., Y. Xia, A. Nguyen, L. Feng, and D. Lo. 1998. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J. Immunol. 161:3128-3135.
25. Spender, L., T. Hussell, and P. Openshaw. 1998. Abundant IFN-γ production by local T cells in respiratory syncytial virus induced eosinophil lung disease. J. Gen. Viral 79:1751-1758.
26. Becker, S., W. Reed, F. Henderson, and T. Noah. 1997. RSV infection of human airway epithelial cells causes production of the β-chemokine RANTES. Am. J. Physiol. 272: L512-L520.
27. Olszewska-Pazdrak, B., A. Casola, T. Saito, R. Alam, S. Crowe, F. Mei, P. Ogra, and R. Garofalo. 1998. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 72:4756-4764.
28. Kimpen, J.L.L., R. Garofalo, R.C. Welliver, and P.L. Ogra. 1992. Activation of human eosinophils in vitro by respiratory syncytial virus. Pediatr. Res. 32:160-164.
29. Handzel, Z.T., W.W. Busse, J.B. Sedgwick, R. Vrtis, W.M. Lee, E.A. Kelly, and J.E. Gern. 1998. Eosinophils bind rhinovirus and activate virus-specific T cells. J. Immunol. 160: 1279-1284.
30. Olszewska-Pazdrak, B., K. Pazdrak, P. Ogra, and R.P. Garofalo. 1998. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism. J. Immunol. 160:4889-4895.
31. Kato, M., R.T. Abraham, S. Okada, and H. Kita. 1998. Ligation of the beta2 integrin triggers activation and degranulation of human eosinophils. Am. J. Respir. Cell Mol. Biol. 18: 675-686.
32. Gleich, G.J., D.A. Loegering, M.P. Bell, J.L. Checkel, S.J. Ackerman, and D.J. McKean. 1986. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc. Natl. Acad. Sci. USA. 83:3146-3150.
33. De, B.P., M.S. Galinski, and A.K. Banerjee. 1990. Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3. J. Virol. 64:1135-1142.
34. Domachowske, J.B., K.D. Dyer, C.A. Bonville, and H.F. Rosenberg. 1998. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J. Infect. Dis. 177:1458-1464.
35. Domachowske, J.B., K.D. Dyer, A.G. Adams, T.L. Leto, and H.F. Rosenberg. 1998. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res. 26:3358-3363.
36. Sanders, S.P., E.S. Siekierski, J.D. Porter, S.M. Richards, and D. Proud. 1998. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J. Virol. 72:934-942.
37. Oliveira, S.H., S.G. Fonseca, P.R. Romao, F. Figueiredo, S.H. Ferreira, and F.Q. Cunha. 1998. Microbicidal activity of eosinophils is associated with activation of the arginine-NO pathway. Parasite Immunol. 20:405-412.
38. Liu, S.F., E.B. Haddad, I. Adcock, M. Salmon, H. Koto, T. Gilbey, P.J. Barnes, and K.F. Chung. 1997. Inducible nitric oxide synthase after sensitization and allergen challenge of Brown Norway rat lung. Br. J. Pharmacol. 121:1241-1246.
39. Kharitonov, S.A., D. Yates, R.A. Robbins, R. Logan-Sinclair, E.A. Shinebourne, and P.J. Barnes. 1994. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 343: 133-135.
40. de Gouw, H.W., K. Grunberg, R. Schot, A.C. Kroes, E.C. Dick, and P.J. Sterk. 1998. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur. Respir. J. 11:126-132.
41. Hiroi, T., M. Yanagita, H. Iijima, K. Iwatani, T. Yoshida, K. Yakatshu, and H. Kiyono. 1999. Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosal-associated tissues. J. Immunol. 162: 821-828.
42. Kopf, M., G. Gros, A. Coyle, M. Kosco-Vilbois, and F. Brombacher. 1995. Immune responses of 1L-4, IL-5, IL-6 deficient mice. Immunol. Rev. 148:45-69.
43. Loughnan, M.S., K. Takatsu, N. Harada, and G.J.V. Nossal. 1987. T cell replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells. Proc. Natl. Acad. Sci. USA. 84:5399-5403.
44. Clutterbuck, E.J., E.M. Hirst, and C.J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood. 73: 1504-1512.
45. Bertolini, J.N., C.J. Sanderson, and E.M. Benson. 1993. Human interleukin-5 induces staphylococcal A Cowan 1 strain-activated human B cells to secrete IgM. Eur. J. Immunol. 23: 398-402.
46. Takatsu, K., Y. Kikuchi, T. Takahashi, T. Honjo, M. Matsumoto, N. Harada, N. Yamaguchi, and A. Tominaga. 1987. Interleukin 5, a T-cell derived B-cell differentiating factor also induces T lymphocytes. Proc. Natl. Acad. Sci. USA. 84: 4234-4238.
47. Scherle, P.A., G. Palladino, and W. Gerhard. 1991. Mice can recover from pulmonary influenza virus infection in the absence of class 1-restricted cytotoxic T cells. J. Immunol. 148: 212-217.
48. Minette, P.A., and P.J. Barnes. 1988. Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. J. Appl. Physiol. 64:2532-2537.
49. Minette, P.A., J.W. Lammers, C.M. Dixon, M.T. McCusker, and P.J. Barnes. 1989. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J. Appl. Physiol. 67:2461-2465.
50. Ayala, L.E., and T. Ahmed. 1989. Is there loss of a protective muscarinic receptor in asthma? Chest. 96:1285-1291.
51. Keen, H., V. Hurst, S. Jack, M.G. Pearson, C. Warburton, P.M.A. Calverley, and R.W. Costello. 1998. Loss of function of pulmonary neuronal M2 receptors in subjects with mild bronchial hyperreactivity during a respiratory tract viral infection. Eur. Respir. J. 12:1495. (Abstr.)
52. Kirby, J.G., F.E. Hargreave, G.J. Gleich, and P.M. O'Byrne. 1987. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am. Rev. Respir. Dis. 136:379-383.